Docon offloads 10% stake in Thyrocare for Rs 668 Cr

Docon Technologies Pvt Ltd, a promoter entity of Thyrocare Technologies, has sold 53.33 lakh equity shares representing around 10% of the company’s total paid-up capital through open market transactions on October 24, 2025.

The sale was valued at Rs 667.7 crore at an average price of Rs 1,252 per share, according to a stock exchange filing.

Following the transaction, Docon’s shareholding in Thyrocare has come down from 71% to 61% and continues to remain a promoter of the diagnostics chain with 3.2 crore shares. 

The block sale saw strong…